Compound Detail
CHEMBL309660
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL309660 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QWVPSLXKIGGBPP-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
432.6
MW (Da)
5.06
ALogP
3
HBA
0
HBD
40.6
PSA (Ų)
0.50
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 7.46 | 7.46 | 35.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 7.1 | 7.1 | 80.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Serotonin 2 (5-HT2) receptor | IC50 | = | 10.0 | nM | 8.0 | The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptam... | 1908521 |
| Adrenergic receptor alpha-1 | IC50 | = | 35.0 | nM | 7.46 | The concentration required to inhibit [3H]prazosin binding to Alpha-1 adrenergic... | 1908521 |
| D(2) dopamine receptor | IC50 | = | 80.0 | nM | 7.1 | The concentration required to inhibit [3H]spiperone binding to dopamine receptor... | 1908521 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1908521 | 10.1021/jm00112a025 | Serotonin 2 (5-HT2) receptor | 1 |
| 1908521 | 10.1021/jm00112a025 | Adrenergic receptor alpha-1 | 1 |
| 1908521 | 10.1021/jm00112a025 | D(2) dopamine receptor | 1 |
Data from ChEMBL 36 via Core Engine